Crohn's Disease and Upper Respiratory Infections
Crohn's disease itself does not directly cause upper respiratory infections, but patients with Crohn's disease—particularly those on immunosuppressive therapy or with active disease—have a significantly increased risk of developing these infections.
The Disease vs. The Treatment
The relationship between Crohn's disease and upper respiratory infections is primarily mediated through two mechanisms:
1. Immunosuppressive Medications
The medications used to treat Crohn's disease substantially increase infection risk. Systemic corticosteroids are the most significant risk factor, with concurrent prednisolone use increasing the odds of respiratory pathogen detection by 2.78-fold 1. The ECCO guidelines emphasize that combination therapies carry particularly high risk, with odds ratios increasing from 2.9 for single immunosuppressive drugs to 14.5 for two or three agents combined 2. The combinations of thiopurines plus steroids or thiopurines plus steroids plus infliximab present the greatest risk 2.
Interestingly, advanced biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab) and immunomodulators alone do not significantly increase respiratory pathogen detection risk 1. This suggests that the steroid component is the primary driver of respiratory infection susceptibility.
2. Active Disease State
Each 100-point increase in the Crohn's Disease Activity Index is associated with a 30% increased risk of opportunistic infections 2. Patients with active IBD demonstrate significantly higher odds of respiratory infections, including RSV (adjusted OR 1.55), bacterial pneumonia (OR 2.58), and more severe outcomes requiring ICU admission (OR 2.07) 3.
Population-Level Risk Data
A large UK primary care study of 18,829 IBD patients demonstrated that 46% of people with IBD presented with common infections versus 37% of matched controls, with increased risks across common infections (HR 1.12-1.83) and viral infections specifically 4. This represents real-world infection burden in contemporary practice.
Critical Caveats
Direct respiratory tract involvement by Crohn's disease itself is extraordinarily rare—limited to case reports of granulomatous bronchial lesions 5, 6. This is not what causes the increased infection risk you should be concerned about clinically.
The temporal analysis showing similar monthly fluctuations between Crohn's disease and bacterial intestinal infections—but not respiratory infections—suggests that respiratory infections follow different epidemiological patterns than IBD exacerbations 7.
Clinical Implications
- Minimize steroid exposure through early introduction of steroid-sparing agents 1
- Maintain vigilance for infections particularly when using systemic corticosteroids, immunotherapies, or biologic agents 4
- Additional risk factors compound infection risk: malnutrition (OR 2.31), obesity (OR 1.07 per kg/m²), older age (>65 years shows up to 20-fold increased severe infection risk), and comorbidities 2
- RSV vaccination appears protective: among vaccinated patients, RSV infection rates were not significantly different between active and nonactive IBD 3